Latest Anti-diabetic drug Stories
RIDGEFIELD, Conn., June 6 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced its pipeline of oral antidiabetic compounds, establishing itself in the type 2 diabetes therapeutic area.
Two-year study presented at the American Diabetes Association's 69th Scientific Sessions shows investigational product comparable to standard insulin therapy in pulmonary function tests NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin with changes in pulmonary function tests comparable to usual antidiabetic treatment, according to data presented today at the American Diabetes Association's...
Today's announcement hurts thousands of Avandia patients, counsel says HOUSTON, June 5 /PRNewswire/ -- Noted Houston trial lawyer Mark Lanier of The Lanier Law Firm says "useless trick science" is the basis for a new study being unveiled today in New Orleans by drug maker GlaxoSmithKline (NYSE: GSK) about the side effects caused by the company's diabetes medication Avandia, which reportedly has been linked to heart problems in thousands of patients. Mr.
Results show improved insulin sensitivity and lower glucose levels without the side effects of current therapies KALAMAZOO, Mich., May 14 /PRNewswire/ -- Metabolic Solutions Development Company (MSDC) announced today that its lead compound, MSDC-0160, can improve insulin sensitivity and lower blood glucose levels in humans without the side effects of current therapies when taken over a 28-day period, according to preliminary data derived from the company's Phase IIa clinical trial.
Approximately 60 Percent of Patients Reached American Diabetes Association's Recommended Average Blood Sugar Level PRINCETON, N.J., May 8 /PRNewswire/ -- Novo Nordisk today announced results from the TITRATE(R) study showing that Levemir(R) (insulin detemir [rDNA origin] injection), taken once-daily, substantially lowered average blood sugar.
- Ben Vereen to Extend National Diabetes Awareness Campaign in Six Additional Cities - BRIDGEWATER, N.J., April 21 /PRNewswire-FirstCall/ -- Tony Award-winning actor and Broadway star Ben Vereen will reprise his role as a diabetes advocate and again Take the Stage for Diabetes Awareness with sanofi-aventis U.S.
Ben Vereen to Extend National Diabetes Awareness Campaign in Six Additional Cities BRIDGEWATER, N.J., April 21 /PRNewswire/ -- Tony Award-winning actor and Broadway star Ben Vereen will reprise his role as a diabetes advocate and again Take the Stage for Diabetes Awareness with sanofi-aventis U.S.
Researchers at the University of Toronto and St.
The majority of patients with type 1 diabetes who underwent a certain type of stem cell transplantation became insulin free, several for more than three years, with good glycemic control, and also increased C-peptide levels, an indirect measure of beta-cell function, according to a study in the April 15 issue of JAMA, a theme issue on diabetes.
A major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater patient satisfaction.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.